Timothy William Watts, Chief Financial Officer & Company Secretary at Oxford BioMedica, holds 1.75M shares in Shield Therapeutics (Ticker: GB:STX), holds 27.57K shares in Fusion Antibodies Plc (Ticker: GB:FAB), holds 17.18M shares in Oxford BioMedica (Ticker: OXBDF). Most recently, Timothy William Watts Bought ― shares of Shield Therapeutics on Feb 26, 2021 for an estimated value of 300.00K.